| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9945093 | The Annals of Thoracic Surgery | 2005 | 7 Pages |
Abstract
Adverse events after implantation of Mitroflow aortic bioprosthesis rarely occurred during the first 5 years after valve replacement. The results of the prosthesis indicates reliable long-term morbidity rates and good durability in patients 75 years of age and older.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kazutomo MD, Armin PhD, Sebastian MD, Heinrich MD, Reiner MD,